0.00
Schlusskurs vom Vortag:
$15.68
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$9.35M
Einnahmen:
$9.81M
Nettoeinkommen (Verlust:
$-26.16M
KGV:
0.00
EPS:
-38.77
Netto-Cashflow:
$-17.45M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Firmenname
Reshape Lifesciences Inc
Sektor
Branche
Telefon
949-429-6680
Adresse
1001 CALLE AMANECER, SAN CLEMENTE
Vergleichen Sie RSLS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
RSLS
Reshape Lifesciences Inc
|
0.00 | 9.35M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
126.86 | 223.39B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.95 | 136.67B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
351.69 | 135.88B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.72 | 126.37B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.32 | 48.39B | 5.88B | 1.34B | 799.60M | 2.3489 |
Reshape Lifesciences Inc Aktie (RSLS) Neueste Nachrichten
Global Medical Tourism Market to Reach USD 58 Billion by 2032, Due to Shift Toward Affordable, Quality Healthcare Abroad | DelveInsight - Business Upturn
Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? - Yahoo Finance
HIND Stock Price and Chart — NASDAQ:HIND - TradingView
Is ReShape Lifesciences Inc. stock a smart buy before Fed meetingEarnings Miss & Safe Swing Trade Setups - Newser
Will ReShape Lifesciences Inc. stock recover faster than peersBear Alert & Community Trade Idea Sharing - Newser
Is ReShape Lifesciences Inc. stock dividend yield sustainableWeekly Investment Summary & AI Optimized Trading Strategy Guides - Newser
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause - MSN
Vyome Holdings Inc. Reports Post-Merger Financials - MSN
Why ReShape Lifesciences Inc. stock is rated strong buyDay Trade & Smart Allocation Stock Tips - newser.com
Will ReShape Lifesciences Inc. stock maintain dividend yieldJuly 2025 Breakouts & Smart Money Movement Tracker - newser.com
How ReShape Lifesciences Inc. stock performs in rising dollar environmentMarket Performance Summary & Risk Controlled Swing Alerts - newser.com
Live market analysis of ReShape Lifesciences Inc.July 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Tools to monitor ReShape Lifesciences Inc. recovery probability2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
Comparing ReShape Lifesciences Inc. in custom built stock radarsTrade Entry Summary & Low Volatility Stock Suggestions - newser.com
Is now a turning point for ReShape Lifesciences Inc.Profit Target & Stepwise Entry/Exit Trade Alerts - newser.com
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism - MSN
Will ReShape Lifesciences Inc. stock benefit from green energy trendsTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
Why ReShape Lifesciences Inc. stock is a must watch in 2025July 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
Is ReShape Lifesciences Inc. stock safe for conservative investorsPortfolio Return Summary & Weekly Momentum Picks - newser.com
Head-To-Head Analysis: ReShape Lifesciences (OTCMKTS:RSLSD) versus Bioventus (NASDAQ:BVS) - Defense World
United States Weight Loss Devices Market 2025: Top - openPR.com
Will earnings trigger a reversal in ReShape Lifesciences Inc.2025 Growth vs Value & Long-Term Growth Plans - newser.com
Finanzdaten der Reshape Lifesciences Inc-Aktie (RSLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):